2019 FAST Summit on Angelman Syndrome - ASO Therapy for AS - Dr. Frank Bennett, Ionis Pharmaceutical
2019 FAST Summit on Angelman Syndrome - NNZ-2591 for AS - Dr. Larry Glass, Neuren PharmaceuticalsПодробнее
2019 FAST Summit on Angelman Syndrome - Genetics and Therapeutic Overview, Allyson Berent, CSO FASTПодробнее
2019 FAST Summit on Angelman Syndrome - AAV Gene Therapy - Dr. Edwin Weeber, PTC TherapueticsПодробнее
2019 FAST Summit on Angelman Syndrome - ASO for potential treatment of AS - GeneTx BiotherapeuticsПодробнее
2019 FAST Science Summit on Angelman Syndrome - Keynote, Dr. Emil Kakkis, Ultragenyx PharmaceuticalПодробнее
2019 FAST Summit on Angelman Syndrome -Update on the Natural History Study in Angelman SyndromeПодробнее
2019 FAST Summit on Angelman Syndrome - The FREESIAS Study - Dr. Michelle Krishnan RocheПодробнее
2019 FAST Summit on Angelman Syndrome - Round Table Discussion on Development of Therapies for ASПодробнее
Updates on the Development of an ASO Therapy for Angelman Syndrome Dr Becky Crean 2020 FAST ScienceПодробнее
2019 FAST Summit on Angelman Syndrome: Best Practices to Ensure a Successful AAC Eval-Lara BeauchampПодробнее
GeneTx WebinarПодробнее
2019 FAST Summit on Angelman Syndrome - HSC Therapy - Dr. Joe Anderson, Dr. Mehrdad Abedi, UC DavisПодробнее
2019 FAST Summit on Angelman Syndrome - Ketone Supplementation in AS, Disruptive EnterprisesПодробнее
Rebecca Crean | 2022 FAST Summit on Angelman SyndromeПодробнее
2019 FAST Summit on Angelman Syndrome - OV101 for the Treatment of AS, Dr. Amit Rhakit, OvidПодробнее
2019 FAST Summit on Angelman Syndrome: Motor Development in Angelman Syndrome- Amy Eapen PT, DPTПодробнее
